For: | Assimakopoulos SF, Scopa CD, Nikolopoulou VN, Vagianos CE. Pleiotropic effects of bombesin and neurotensin on intestinal mucosa: Not just trefoil peptides. World J Gastroenterol 2008; 14(22): 3602-3603 [PMID: 18567096 DOI: 10.3748/wjg.14.3602] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i22/3602.htm |
Number | Citing Articles |
1 |
Kara Gross Margolis, Michael David Gershon. Neuropeptides and inflammatory bowel disease. Current Opinion in Gastroenterology 2009; 25(6): 503 doi: 10.1097/MOG.0b013e328331b69e
|
2 |
Lucília Pereira da Silva, Bruno Miguel Neves, Liane Moura, Maria Teresa Cruz, Eugénia Carvalho. Neurotensin Decreases the Proinflammatory Status of Human Skin Fibroblasts and Increases Epidermal Growth Factor Expression. International Journal of Inflammation 2014; 2014: 1 doi: 10.1155/2014/248240
|
3 |
Lucília da Silva, Bruno Miguel Neves, Liane Moura, Maria Teresa Cruz, Eugénia Carvalho. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(10): 1863 doi: 10.1016/j.bbamcr.2011.06.018
|
4 |
Simona Deiana, Tommaso Gabbani, Siro Bagnoli, Vito Annese. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opinion on Emerging Drugs 2015; 20(2): 247 doi: 10.1517/14728214.2015.1013935
|
5 |
Guillermo A. Gomez, Ella W. Englander, George H. Greeley. Physiology of the Gastrointestinal Tract. 2012; : 155 doi: 10.1016/B978-0-12-382026-6.00007-5
|